Divis Laboratories Ltd | DIVI - Gross Profit On Sales

Stock Price
6,932.00
Daily Change
97.00 1.42%
Monthly
10.38%
Yearly
7.43%
Q2 Forecast
6,615.83

Divis Laboratories Ltd reported INR16.59B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Aurobindo Pharma INR 51.23B 1.76B Dec/2025
Avita Medical AUD 14.31M 639K Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Ionis Pharmaceuticals USD 243M 48M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Lupin INR 49.76B 704.6M Dec/2025
Moderna USD -566M 792M Mar/2026
Organon & Co USD 854M 3M Dec/2025
Revvity USD 387.66M 34M Mar/2026
Tectonic Therapeutic USD 0 0 Mar/2025
Tilray USD 57.47M 10.16M Jun/2025
Viatris USD 1.38B 229.9M Mar/2026
Xeris Pharmaceuticals USD 72.15M 8.77M Dec/2025